{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:37:43Z","timestamp":1775594263506,"version":"3.50.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/nrrheum.2010.178","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T10:54:20Z","timestamp":1289904860000},"page":"13-22","source":"Crossref","is-referenced-by-count":239,"title":["Pharmacologic therapy for osteoarthritis\u2014the era of disease modification"],"prefix":"10.1038","volume":"7","author":[{"given":"David J.","family":"Hunter","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"BFnrrheum2010178_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s003930050164","volume":"58","author":"G Nuki","year":"1999","unstructured":"Nuki, G. Osteoarthritis: a problem of joint failure. Z. Rheumatol. 58, 142\u2013147 (1999).","journal-title":"Z. Rheumatol."},{"issue":"Suppl.","key":"BFnrrheum2010178_CR2","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1097\/01.blo.0000144855.48640.b9","volume":"427","author":"DR Eyre","year":"2004","unstructured":"Eyre, D. R. Collagens and cartilage matrix homeostasis. Clin. Orthop. Relat. Res. 427 (Suppl.), S118\u2013S122 (2004).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrrheum2010178_CR3","first-page":"2271","volume":"33","author":"CF Dillon","year":"2006","unstructured":"Dillon, C. F., Rasch, E. K., Gu, Q. & Hirsch, R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991\u201394. J. Rheumatol. 33, 2271\u20132279 (2006).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2010178_CR4","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence and impact of chronic joint symptoms\u2014seven states, 1996. MMWR Morb. Mortal. Wkly Rep. 47, 345\u2013351 (1998)."},{"key":"BFnrrheum2010178_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/1529-0131(200101)44:1<212::AID-ANR28>3.0.CO;2-Q","volume":"44","author":"DD Dunlop","year":"2001","unstructured":"Dunlop, D. D., Manheim, L. M., Song, J. & Chang, R. W. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum. 44, 212\u2013221 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence, R. C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41, 778\u2013799 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/aje\/kwf141","volume":"156","author":"Y Zhang","year":"2002","unstructured":"Zhang, Y. et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am. J. Epidemiol. 156, 1021\u20131027 (2002).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrrheum2010178_CR8","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults\u2014United States, 1999. MMWR Morb. Mortal. Wkly Rep. 50, 120\u2013125 (2001)."},{"key":"BFnrrheum2010178_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2105\/AJPH.84.3.351","volume":"84","author":"AA Guccione","year":"1994","unstructured":"Guccione, A. A. et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am. J. Public Health 84, 351\u2013358 (1994).","journal-title":"Am. J. Public Health"},{"key":"BFnrrheum2010178_CR10","unstructured":"Centers for Disease Control and Prevention (CDC). Arthritis prevalence and activity limitations\u2014United States, 1990. MMWR Morb. Mortal. Wkly Rep. 43, 433\u2013438 (1994)."},{"key":"BFnrrheum2010178_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0033-8389(03)00161-1","volume":"42","author":"DT Felson","year":"2004","unstructured":"Felson, D. T. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol. Clin. North Am. 42, 1\u20139 (2004).","journal-title":"Radiol. Clin. North Am."},{"key":"BFnrrheum2010178_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.joca.2009.08.010","volume":"18","author":"M Blagojevic","year":"2010","unstructured":"Blagojevic, M., Jinks, C., Jeffery, A. & Jordan, K. P. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 18, 24\u201333 (2010).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00167-009-0901-2","volume":"18","author":"JH Yoo","year":"2010","unstructured":"Yoo, J. H. et al. A meta-analysis of the effect of neuromuscular training on the prevention of the anterior cruciate ligament injury in female athletes. Knee Surg. Sports Traumatol. Arthrosc. 18, 824\u2013830 (2010).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"BFnrrheum2010178_CR14","first-page":"1037","volume":"158","author":"RH Glazier","year":"1998","unstructured":"Glazier, R. H. et al. Management of common musculoskeletal problems: a survey of Ontario primary care physicians. CMAJ 158, 1037\u20131040 (1998).","journal-title":"CMAJ"},{"key":"BFnrrheum2010178_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-008-0004-y","volume":"10","author":"DJ Hunter","year":"2008","unstructured":"Hunter, D. J. Are there promising biologic therapies for osteoarthritis? Curr. Rheumatol. Rep. 10, 19\u201325 (2008).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum2010178_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/art.23934","volume":"59","author":"SP Desai","year":"2008","unstructured":"Desai, S. P. et al. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum. 59, 1058\u20131073 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/BOR.0b013e3283235add","volume":"21","author":"DJ Hunter","year":"2009","unstructured":"Hunter, D. J., Le Graverand, M. P. & Eckstein, F. Radiologic markers of osteoarthritis progression. Curr. Opin. Rheumatol. 21, 110\u2013117 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2010178_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/rheumatology\/kei171","volume":"45","author":"G Verbruggen","year":"2006","unstructured":"Verbruggen, G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 45, 129\u2013138 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2010178_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.rdc.2008.05.003","volume":"34","author":"DJ Hunter","year":"2008","unstructured":"Hunter, D. J. & Hellio Le Graverand-Gastineau, M. P. How close are we to having structure-modifying drugs available? Rheum. Dis. Clin. North Am. 34, 789\u2013802 (2008).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum2010178_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/138945010791011893","volume":"11","author":"MP Le Graverand-Gastineau","year":"2010","unstructured":"Le Graverand-Gastineau, M. P. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets. Curr. Drug Targets 11, 528\u2013535 (2010).","journal-title":"Curr. Drug Targets"},{"key":"BFnrrheum2010178_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/ncprheum0193","volume":"2","author":"SB Abramson","year":"2006","unstructured":"Abramson, S. B., Attur, M. & Yazici, Y. Prospects for disease modification in osteoarthritis. Nat. Clin. Pract. Rheumatol. 2, 304\u2013312 (2006).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"BFnrrheum2010178_CR22","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.21122","volume":"52","author":"KD Brandt","year":"2005","unstructured":"Brandt, K. D. et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 52, 2015\u20132025 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR23","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T","volume":"44","author":"M Dougados","year":"2001","unstructured":"Dougados, M. et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip. Arthritis Rheum. 44, 2539\u20132547 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR24","unstructured":"OARSI FDA OA initiative. www.oarsi.org [online] , (2009)."},{"key":"BFnrrheum2010178_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrd1693","volume":"4","author":"HA Wieland","year":"2005","unstructured":"Wieland, H. A., Michaelis, M., Kirschbaum, B. J. & Rudolphi, K. A. Osteoarthritis\u2014an untreatable disease? Nat. Rev. Drug Discov. 4, 331\u2013344 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrrheum2010178_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/rheumatology\/keh436","volume":"44","author":"S Jacobsen","year":"2005","unstructured":"Jacobsen, S. & Sonne-Holm, S. Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey. Rheumatology (Oxford) 44, 211\u2013218 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2010178_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.knee.2004.12.006","volume":"12","author":"MR Utting","year":"2005","unstructured":"Utting, M. R., Davies, G. & Newman, J. H. Is anterior knee pain a predisposing factor to patellofemoral osteoarthritis? Knee 12, 362\u2013365 (2005).","journal-title":"Knee"},{"key":"BFnrrheum2010178_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0002-9343(02)01447-X","volume":"114","author":"EW Karlson","year":"2003","unstructured":"Karlson, E. W. et al. Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am. J. Med. 114, 93\u201398 (2003).","journal-title":"Am. J. Med."},{"key":"BFnrrheum2010178_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/art.21659","volume":"54","author":"GB Flugsrud","year":"2006","unstructured":"Flugsrud, G. B. et al. The impact of body mass index on later total hip arthroplasty for primary osteoarthritis: a cohort study in 1.2 million persons. Arthritis Rheum. 54, 802\u2013807 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/01.bor.0000172800.49120.97","volume":"17","author":"DT Felson","year":"2005","unstructured":"Felson, D. T. The sources of pain in knee osteoarthritis. Curr. Opin. Rheumatol. 17, 624\u2013628 (2005).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2010178_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2174\/138945010791011947","volume":"11","author":"DJ Hunter","year":"2010","unstructured":"Hunter, D. J. et al. A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Curr. Drug Targets 11, 536\u2013545 (2010).","journal-title":"Curr. Drug Targets"},{"key":"BFnrrheum2010178_CR32","first-page":"1432","volume":"34","author":"L Gossec","year":"2007","unstructured":"Gossec, L. et al. OMERACT\/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J. Rheumatol. 34, 1432\u20131435 (2007).","journal-title":"J. Rheumatol."},{"issue":"Suppl. A","key":"BFnrrheum2010178_CR33","doi-asserted-by":"publisher","first-page":"A10","DOI":"10.1016\/j.joca.2006.02.021","volume":"14","author":"MN Lassere","year":"2006","unstructured":"Lassere, M. N. A users guide to measurement in medicine. Osteoarthritis Cartilage 14 (Suppl. A), A10\u2013A13 (2006).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR34","unstructured":"Clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA). www.fda.gov [online] , (1999)."},{"key":"BFnrrheum2010178_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.joca.2006.03.005","volume":"14","author":"F Eckstein","year":"2006","unstructured":"Eckstein, F. et al. Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage 14, 974\u2013983 (2006).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR36","unstructured":"Kraus, V. B. & Burnett, B. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (in press)."},{"key":"BFnrrheum2010178_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.joca.2009.01.007","volume":"17","author":"P Ornetti","year":"2009","unstructured":"Ornetti, P. et al. OARSI-OMERACT definition of relevant radiological progression in hip\/knee osteoarthritis. Osteoarthritis Cartilage 17, 856\u2013863 (2009).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.rdc.2008.04.006","volume":"34","author":"A Guermazi","year":"2008","unstructured":"Guermazi, A. et al. Imaging in osteoarthritis. Rheum. Dis. Clin. North Am. 34, 645\u2013687 (2008).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum2010178_CR39","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/ard.2006.058347","volume":"65","author":"KD Brandt","year":"2006","unstructured":"Brandt, K. D., Radin, E. L., Dieppe, P. A. & van de Putte, L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 65, 1261\u20131264 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2010178_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.joca.2006.10.012","volume":"15","author":"NA Papaioannou","year":"2007","unstructured":"Papaioannou, N. A. et al. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthritis Cartilage 15, 386\u2013395 (2007).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.joca.2006.03.014","volume":"14","author":"MA Karsdal","year":"2006","unstructured":"Karsdal, M. A. et al. Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? Osteoarthritis Cartilage 14, 617\u2013624 (2006).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1196\/annals.1402.041","volume":"1117","author":"MA Karsdal","year":"2007","unstructured":"Karsdal, M. A., Sondergaard, B. C., Arnold, M. & Christiansen, C. Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann. NY Acad. Sci. 1117, 181\u2013195 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2010178_CR43","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/acr.20260","volume":"62","author":"TJ Schnitzer","year":"2010","unstructured":"Schnitzer, T. J. New pharmacologic approaches in the management of osteoarthritis. Arthritis Care Res. (Hoboken) 62, 1174\u20131180 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum2010178_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.joca.2009.08.004","volume":"18","author":"MA Karsdal","year":"2010","unstructured":"Karsdal, M. A. et al. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthritis Cartilage 18, 150\u2013159 (2010).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00063030-200822030-00001","volume":"22","author":"MA Karsdal","year":"2008","unstructured":"Karsdal, M. A., Henriksen, K., Arnold, M. & Christiansen, C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs 22, 137\u2013144 (2008).","journal-title":"BioDrugs"},{"key":"BFnrrheum2010178_CR46","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1002\/art.22075","volume":"54","author":"DH Manicourt","year":"2006","unstructured":"Manicourt, D. H., Azria, M., Mindeholm, L., Thonar, E. J. & Devogelaer, J. P. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 54, 3205\u20133211 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR47","unstructured":"Efficacy and safety of oral salmon calcitonin in patients with knee osteoarthritis. ClinicalTrials.gov identifier: NCT00486434 [online] , (2010)."},{"key":"BFnrrheum2010178_CR48","unstructured":"Efficacy and safety of oral salmon calcitonin in patients with knee osteoarthritis (OA 2 study). ClinicalTrials.gov identifier: NCT00704847 [online] , (2010)."},{"issue":"Suppl. 2","key":"BFnrrheum2010178_CR49","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2463","volume":"10","author":"SB Abramson","year":"2008","unstructured":"Abramson, S. B. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res. Ther. 10 (Suppl. 2), S2 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2010178_CR50","unstructured":"A long-term, placebo-controlled X-ray study investigating the safety and efficacy of SD-6010 in subjects with osteoarthritis of the knee (ITIC). ClinicalTrials.gov identifier: NCT00565812 [online] , (2010)."},{"key":"BFnrrheum2010178_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03009740701483014","volume":"36","author":"K Vuolteenaho","year":"2007","unstructured":"Vuolteenaho, K., Moilanen, T., Knowles, R. G. & Moilanen, E. The role of nitric oxide in osteoarthritis. Scand. J. Rheumatol. 36, 247\u2013258 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum2010178_CR52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1073\/pnas.93.2.878","volume":"93","author":"DL Griffith","year":"1996","unstructured":"Griffith, D. L., Keck, P. C., Sampath, T. K., Rueger, D. C. & Carlson, W. D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc. Natl Acad. Sci. USA 93, 878\u2013883 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2010178_CR53","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0962-8924(94)90202-X","volume":"4","author":"J Massagu\u00e9","year":"1994","unstructured":"Massagu\u00e9, J., Attisano, L. & Wrana, J. L. The TGF-beta family and its composite receptors. Trends Cell Biol. 4, 172\u2013178 (1994).","journal-title":"Trends Cell Biol."},{"key":"BFnrrheum2010178_CR54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","volume":"20","author":"C Sieber","year":"2009","unstructured":"Sieber, C., Kopf, J., Hiepen, C. & Knaus, P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20, 343\u2013355 (2009).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"16 Suppl. 1","key":"BFnrrheum2010178_CR55","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007632-200208151-00002","volume":"27","author":"JM Wozney","year":"2002","unstructured":"Wozney, J. M. Overview of bone morphogenetic proteins. Spine (Phila. PA 1976) 27 (16 Suppl. 1), S2\u2013S8 (2002).","journal-title":"Spine (Phila. PA 1976)"},{"key":"BFnrrheum2010178_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00003086-199603000-00005","volume":"324","author":"SD Cook","year":"1996","unstructured":"Cook, S. D. & Rueger, D. C. Osteogenic protein-1: biology and applications. Clin. Orthop. Relat. Res. 324, 29\u201338 (1996).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrrheum2010178_CR57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0736-0266(03)00055-X","volume":"21","author":"C Merrihew","year":"2003","unstructured":"Merrihew, C. et al. Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage. J. Orthop. Res. 21, 899\u2013907 (2003).","journal-title":"J. Orthop. Res."},{"key":"BFnrrheum2010178_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.joca.2004.01.008","volume":"12","author":"Y Nishida","year":"2004","unstructured":"Nishida, Y., Knudson, C. B. & Knudson, W. Osteogenic protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthritis Cartilage 12, 374\u2013382 (2004).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/08977190109001079","volume":"19","author":"M Jelic","year":"2001","unstructured":"Jelic, M. et al. Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep. Growth Factors 19, 101\u2013113 (2001).","journal-title":"Growth Factors"},{"issue":"Suppl. 3","key":"BFnrrheum2010178_CR60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2106\/00004623-200300003-00018","volume":"85-A","author":"SD Cook","year":"2003","unstructured":"Cook, S. D., Patron, L. P., Salkeld, S. L. & Rueger, D. C. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J. Bone Joint Surg. Am. 85-A (Suppl. 3), 116\u2013123 (2003).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFnrrheum2010178_CR61","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2106\/00004623-199710000-00002","volume":"79","author":"RS Sellers","year":"1997","unstructured":"Sellers, R. S., Peluso, D. & Morris, E. A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 79, 1452\u20131463 (1997).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFnrrheum2010178_CR62","unstructured":"Dose finding study of bone morphogenetic protein 7 (BMP-7) in subjects with osteoarthritis (OA) of the knee. ClinicalTrials.gov identifier: NCT01111045 [online] , (2010)."},{"issue":"Suppl. B","key":"BFnrrheum2010178_CR63","first-page":"30","volume":"9","author":"B White-O'Connor","year":"1986","unstructured":"White-O'Connor, B. & Sobal, J. Nutrient intake and obesity in a multidisciplinary assessment of osteoarthritis. Clin. Ther. 9 (Suppl. B), 30\u201342 (1986).","journal-title":"Clin. Ther."},{"key":"BFnrrheum2010178_CR64","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/1529-0131(199905)42:5<854::AID-ANR3>3.0.CO;2-I","volume":"42","author":"NE Lane","year":"1999","unstructured":"Lane, N. E. et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. Arthritis Rheum. 42, 854\u2013860 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/0003-4819-125-5-199609010-00001","volume":"125","author":"TE McAlindon","year":"1996","unstructured":"McAlindon, T. E. et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann. Intern. Med. 125, 353\u2013359 (1996).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum2010178_CR66","unstructured":"Vitamin D to slow progression of knee osteoarthritis. ClinicalTrials.gov identifier: NCT00306774 [online] , (2010)."},{"key":"BFnrrheum2010178_CR67","unstructured":"Zurich multiple endpoint vitamin D trial in knee OA patients. ClinicalTrials.gov identifier: NCT00599807 [online] , (2010)."},{"key":"BFnrrheum2010178_CR68","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1185\/030079906X148373","volume":"22","author":"AE Bello","year":"2006","unstructured":"Bello, A. E. & Oesser, S. Collagen hydrolyzate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr. Med. Res. Opin. 22, 2221\u20132232 (2006).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnrrheum2010178_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/sarh.2000.9622","volume":"30","author":"RW Moskowitz","year":"2000","unstructured":"Moskowitz, R. W. Role of collagen hydrolyzate in bone and joint disease. Semin. Arthritis Rheum. 30, 87\u201399 (2000).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2010178_CR70","first-page":"2456","volume":"38","author":"M Adam","year":"1991","unstructured":"Adam, M. Therapy for osteoarthritis: which effects have preparations of gelatin? Therapiewoche 38, 2456\u20132461 (1991).","journal-title":"Therapiewoche"},{"issue":"Suppl. 2","key":"BFnrrheum2010178_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09637480802498820","volume":"60","author":"P Benito-Ruiz","year":"2009","unstructured":"Benito-Ruiz, P. et al. A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolyzate, for improving joint comfort. Int. J. Food Sci. Nutr. 60 (Suppl. 2), 99\u2013113 (2009).","journal-title":"Int. J. Food Sci. Nutr."},{"key":"BFnrrheum2010178_CR72","unstructured":"A placebo-controlled study of collagen hydrolyzate in subjects with knee osteoarthritis (OA) (NMR). ClinicalTrials.gov identifier: NCT00536302 [online] , (2009)."},{"key":"BFnrrheum2010178_CR73","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","volume":"13","author":"EE Moore","year":"2005","unstructured":"Moore, E. E. et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 13, 623\u2013631 (2005).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gene.2008.04.019","volume":"420","author":"MB Ellman","year":"2008","unstructured":"Ellman, M. B., An, H. S., Muddasani, P. & Im, H. J. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420, 82\u201389 (2008).","journal-title":"Gene"},{"key":"BFnrrheum2010178_CR75","unstructured":"AS902330 in cartilage injury repair (CIR). ClinicalTrials.gov identifier: NCT01066871 [online] , (2010)."},{"key":"BFnrrheum2010178_CR76","first-page":"1825","volume":"30","author":"YE Henrotin","year":"2003","unstructured":"Henrotin, Y. E. et al. Avocado\/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J. Rheumatol. 30, 1825\u20131834 (2003).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2010178_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10067-003-0731-4","volume":"22","author":"E Ernst","year":"2003","unstructured":"Ernst, E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis\u2014a systematic review. Clin. Rheumatol. 22, 285\u2013288 (2003).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2010178_CR78","first-page":"825","volume":"64","author":"F Blotman","year":"1997","unstructured":"Blotman, F., Maheu, E., Wulwik, A., Caspard, H. & Lopez, A. Efficacy and safety of avocado\/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev. Rhum. Engl. Ed. 64, 825\u2013834 (1997).","journal-title":"Rev. Rhum. Engl. Ed."},{"key":"BFnrrheum2010178_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/030097401316909602","volume":"30","author":"T Appelboom","year":"2001","unstructured":"Appelboom, T., Schuermans, J., Verbruggen, G., Henrotin, Y. & Reginster, J. Y. Symptoms modifying effect of avocado\/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand. J. Rheumatol. 30, 242\u2013247 (2001).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum2010178_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/1529-0131(199801)41:1<81::AID-ART11>3.0.CO;2-9","volume":"41","author":"E Maheu","year":"1998","unstructured":"Maheu, E. et al. Symptomatic efficacy of avocado\/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 41, 81\u201391 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR81","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/art1.10239","volume":"47","author":"M Lequesne","year":"2002","unstructured":"Lequesne, M., Maheu, E., Cadet, C. & Dreiser, R. L. Structural effect of avocado\/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum. 47, 50\u201358 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR82","unstructured":"Evaluation of the structure modifying effect of avocado-soybean unsaponifiables in hip osteoarthritis (ERADIAS). ClinicalTrials.gov identifier: NCT01062737 [online] , (2010)."},{"key":"BFnrrheum2010178_CR83","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1063-4584(03)00153-5","volume":"11","author":"K Rudolphi","year":"2003","unstructured":"Rudolphi, K., Gerwin, N., Verzijl, N., van der Kraan, P. & van den Berg, W. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11, 738\u2013746 (2003).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR84","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.orthres.2003.12.007","volume":"22","author":"X Zhang","year":"2004","unstructured":"Zhang, X., Mao, Z. & Yu, C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J. Orthop. Res. 22, 742\u2013750 (2004).","journal-title":"J. Orthop. Res."},{"key":"BFnrrheum2010178_CR85","first-page":"1411","volume":"190","author":"X Chevalier","year":"2006","unstructured":"Chevalier, X., Mugnier, B. & Bouvenot, G. Targeted anti-cytokine therapies for osteoarthritis. Bull. Acad. Natl Med. 190, 1411\u20131420 (2006).","journal-title":"Bull. Acad. Natl Med."},{"key":"BFnrrheum2010178_CR86","unstructured":"Treatment for patients with osteoarthritis (OA). ClinicalTrials.gov identifier: NCT00110942 [online] , (2008)."},{"key":"BFnrrheum2010178_CR87","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar2315","volume":"9","author":"P Krzeski","year":"2009","unstructured":"Krzeski, P. et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res. Ther. 9, R109 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2010178_CR88","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2174\/092986708784567680","volume":"15","author":"G Tu","year":"2008","unstructured":"Tu, G., Xu, W., Huang, H. & Li, S. Progress in the development of matrix metalloproteinase inhibitors. Curr. Med. Chem. 15, 1388\u20131395 (2008).","journal-title":"Curr. Med. Chem."},{"key":"BFnrrheum2010178_CR89","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2174\/138161207779313551","volume":"13","author":"B Fingleton","year":"2007","unstructured":"Fingleton, B. Matrix metalloproteinases as valid clinical targets. Curr. Pharm. Des. 13, 333\u2013346 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrrheum2010178_CR90","doi-asserted-by":"publisher","first-page":"27781","DOI":"10.1074\/jbc.M703286200","volume":"282","author":"AR Johnson","year":"2007","unstructured":"Johnson, A. R. et al. Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects. J. Biol. Chem. 282, 27781\u201327791 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2010178_CR91","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/art.24629","volume":"60","author":"VM Baragi","year":"2009","unstructured":"Baragi, V. M. et al. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum. 60, 2008\u20132018 (2009).","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"BFnrrheum2010178_CR92","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2166","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett, G. Erosive arthritis. Arthritis Res. Ther. 9 (Suppl. 1), S2 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2010178_CR93","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/138945007779940188","volume":"8","author":"HJ Salminen-Mankonen","year":"2007","unstructured":"Salminen-Mankonen, H. J., Morko, J. & Vuorio, E. Role of cathepsin K in normal joints and in the development of arthritis. Curr. Drug Targets 8, 315\u2013323 (2007).","journal-title":"Curr. Drug Targets"},{"key":"BFnrrheum2010178_CR94","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jor.20325","volume":"25","author":"AR Jones","year":"2007","unstructured":"Jones, A. R. et al. Binding and localization of recombinant lubricin to articular cartilage surfaces. J. Orthop. Res. 25, 283\u2013292 (2007).","journal-title":"J. Orthop. Res."},{"key":"BFnrrheum2010178_CR95","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1074\/jbc.C000848200","volume":"276","author":"M Kashiwagi","year":"2001","unstructured":"Kashiwagi, M., Tortorella, M., Nagase, H. & Brew, K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501\u201312504 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2010178_CR96","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nature03369","volume":"434","author":"SS Glasson","year":"2005","unstructured":"Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644\u2013648 (2005).","journal-title":"Nature"},{"key":"BFnrrheum2010178_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1759720X09342132","volume":"1","author":"D Hunter","year":"2009","unstructured":"Hunter, D. Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects. Ther. Ad. Musc. Dis. 1, 35\u201347 (2009).","journal-title":"Ther. Ad. Musc. Dis."},{"key":"BFnrrheum2010178_CR98","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/ard.2007.082107","volume":"68","author":"DJ Hunter","year":"2009","unstructured":"Hunter, D. J. et al. Change in cartilage morphometry: a sample of the progression cohort of the osteoarthritis initiative. Ann. Rheum. Dis. 68, 349\u2013356 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2010178_CR99","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejrad.2004.01.018","volume":"50","author":"T Karachalios","year":"2004","unstructured":"Karachalios, T. et al. MR imaging findings in early osteoarthritis of the knee. Eur. J. Radiol. 50, 225\u2013230 (2004).","journal-title":"Eur. J. Radiol."},{"key":"BFnrrheum2010178_CR100","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.joca.2008.02.001","volume":"16","author":"S Reichenbach","year":"2008","unstructured":"Reichenbach, S. et al. Prevalence of bone attrition on knee radiographs and MRI in a community-based cohort. Osteoarthritis Cartilage 16, 1005\u20131010 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR101","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1002\/art.21296","volume":"52","author":"S Amin","year":"2005","unstructured":"Amin, S. et al. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum. 52, 3152\u20133159 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR102","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1063-4584(05)80017-2","volume":"3","author":"H Roos","year":"1995","unstructured":"Roos, H., Adalberth, T., Dahlberg, L. & Lohmander, L. S. Osteoarthritis of the knee after injury to the anterior cruciate ligament or meniscus: the influence of time and age. Osteoarthritis Cartilage 3, 261\u2013267 (1995).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR103","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/art.20589","volume":"50","author":"LS Lohmander","year":"2004","unstructured":"Lohmander, L. S., Ostenberg, A., Englund, M. & Roos, H. High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum. 50, 3145\u20133152 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR104","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/art.11088","volume":"48","author":"M Englund","year":"2003","unstructured":"Englund, M., Roos, E. M. & Lohmander, L. S. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum. 48, 2178\u20132187 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR105","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1002\/art.20489","volume":"50","author":"M Englund","year":"2004","unstructured":"Englund, M. & Lohmander, L. S. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum. 50, 2811\u20132819 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.blo.0000197079.26600.09","volume":"442","author":"TP Andriacchi","year":"2006","unstructured":"Andriacchi, T. P., Briant, P. L., Bevill, S. L. & Koo, S. Rotational changes at the knee after ACL injury cause cartilage thinning. Clin. Orthop. Relat. Res. 442, 39\u201344 (2006).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrrheum2010178_CR107","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.joca.2008.06.016","volume":"16","author":"CG Peterfy","year":"2008","unstructured":"Peterfy, C. G., Schneider, E. & Nevitt, M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 16, 1433\u20131441 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR108","doi-asserted-by":"publisher","first-page":"R633","DOI":"10.1186\/ar1716","volume":"7","author":"TD Spector","year":"2005","unstructured":"Spector, T. D. et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res. Ther. 7, R625\u2013R633 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2010178_CR109","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1002\/art.22160","volume":"54","author":"CO Bingham 3rd","year":"2006","unstructured":"Bingham, C. O. 3rd et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 54, 3494\u20133507 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR110","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg, D. O. et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med. 354, 795\u2013808 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2010178_CR111","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster, J. Y. et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357, 251\u2013256 (2001).","journal-title":"Lancet"},{"key":"BFnrrheum2010178_CR112","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelk\u00e1","year":"2002","unstructured":"Pavelk\u00e1, K. et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch. Intern. Med. 162, 2113\u20132123 (2002).","journal-title":"Arch. Intern. Med."},{"key":"BFnrrheum2010178_CR113","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/art.24255","volume":"60","author":"A Kahan","year":"2009","unstructured":"Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P. D. & Reginster, J. Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 60, 524\u2013533 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2010178_CR114","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/ard.2008.088732","volume":"68","author":"JP Raynauld","year":"2009","unstructured":"Raynauld, J. P. et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicenter clinical trial using quantitative MRI. Ann. Rheum. Dis. 68, 938\u2013947 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2010178_CR115","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1063-4584(97)80010-6","volume":"5","author":"V Listrat","year":"1997","unstructured":"Listrat, V. et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5, 153\u2013160 (1997).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum2010178_CR116","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1742-1241.2003.tb10535.x","volume":"57","author":"RW Jubb","year":"2003","unstructured":"Jubb, R. W., Piva, S., Beinat, L., Dacre, J. & Gishen, P. A one-year, randomised, placebo (saline) controlled clinical trial of 500\u2013730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int. J. Clin. Pract. 57, 467\u2013474 (2003).","journal-title":"Int. J. Clin. Pract."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2010.178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2010.178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2010.178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T06:32:58Z","timestamp":1685860378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2010.178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFnrrheum2010178"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2010.178","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}